Micromotor-Enabled Active Hydrogen and Tobramycin Delivery for Synergistic Sepsis Therapy
Read more:
DOI:
10.1002/advs.202303759
DOI is the universal ID for this study.
This link will take you to the full study.
Abstract:
Sepsis is a highly heterogeneous syndrome normally characterized by bacterial infection and dysregulated systemic inflammatory response that leads to multiple organ failure and death. Single anti-inflammation or anti-infection treatment exhibits limited survival benefit for severe cases. Here a biodegradable tobramycin-loaded magnesium micromotor (Mg-Tob motor) is successfully developed as a potential hydrogen generator and active antibiotic deliverer for synergistic therapy of sepsis. The peritoneal fluid of septic mouse provides an applicable space for Mg-water reaction. Hydrogen generated sustainably and controllably from the motor interface propels the motion to achieve active drug delivery along with attenuating hyperinflammation. The developed Mg-Tob motor demonstrates efficient protection from anti-inflammatory and antibacterial activity both in vitro and in vivo. Importantly, it prevents multiple organ failure and significantly improves the survival rate up to 87.5% in a high-grade sepsis model with no survival, whereas only about half of mice survive with the individual therapies. This micromotor displays the superior therapeutic effect of synergistic hydrogen-chemical therapy against sepsis, thus holding great promise to be an innovative and translational drug delivery system to treat sepsis or other inflammation-related diseases in the near future.| Publish Year | 2023 |
|---|---|
| Country | China |
| Rank | Positive |
| Journal | Advanced Science |
| Primary Topic | Whole Body |
| Secondary Topic | Sepsis |
| Model | Mouse |
| Tertiary Topic | Multiple Organ Dysfunction Syndrome |
| Vehicle | Gas (Sustained Release) |
| pH | N/A |
| Application | Injection |
| Comparison | |
| Complement | Tobramycin |